戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 observed in the US experience with universal mass vaccination.
2 the development of vaccines that allow rapid mass vaccination.
3 nted more cases per dose of vaccine than did mass vaccination.
4 eted vaccination increased more than that of mass vaccination.
5 ality, non-pharmaceutical interventions, and mass-vaccination.
6                                 We find that mass vaccination activities in Africa reduced deaths by
7 ed with these estimates of R(0) suggest that mass vaccination against cholera deployed strategically
8                    There is a consensus that mass vaccination against SARS-CoV-2 will ultimately end
9 e of clinical and cosmetic uses of BoNT make mass vaccination against the toxin undesirable and impra
10                                              Mass vaccination allows us to study how immunity operate
11 y of LAIVs should be closely monitored after mass vaccination and that novel strategies to continue t
12 s and relatively modest compared to a simple mass vaccination approach under high vaccine availabilit
13 exclusion and coexistence of serotypes under mass vaccination are derived, and the equilibrium carria
14                        The arguments against mass vaccination are that the effectiveness of BCG in pr
15                                              Mass vaccinations are crucial public health intervention
16 argeted vaccination be more competitive with mass vaccination at both preventing and containing a del
17  of protection provided by MenB-4C following mass vaccination at regional level.
18 ity to control dog populations and implement mass vaccination because of financial, logistical and ot
19                                              Mass vaccination before smallpox introduction or immedia
20             In December 2020, Israel began a mass vaccination campaign against coronavirus disease 20
21 d-December 2020, Israel started a nationwide mass vaccination campaign against coronavirus disease 20
22  to bats is critical with the current global mass vaccination campaign against this virus.
23 e were offered oral cholera vaccine during a mass vaccination campaign between March 30 and April 30,
24 population immunity to measles virus after a mass vaccination campaign in a region with high HIV prev
25 with reduced rates of gonorrhoea following a mass vaccination campaign in New Zealand.
26                                        For a mass vaccination campaign involving mass vaccination cen
27                                  Following a mass vaccination campaign of all persons 1-29 years of a
28 e successful introduction of MenAfriVac in a mass vaccination campaign targeting 1- to 29-year-olds i
29 ates; 2) predict the effect of the influenza mass vaccination campaign that began in October 2009 on
30                                     A 1-week mass vaccination campaign was done with Typbar-TCV (Bhar
31       In efforts to control this epidemic, a mass vaccination campaign was held in April 1995.
32 010, Africa's first preventive meningococcal mass vaccination campaign was launched using a newly dev
33                                A countrywide mass vaccination campaign with the use of an inactivated
34                                     During a mass vaccination campaign, adults at a clinic in Odessa
35 e real-life effect of an unprecedented rapid mass vaccination campaign.
36 age groups up to 2 years after Mali's PsA-TT mass vaccination campaign.
37                   Data were collected during mass vaccination campaigns (MVCs), contact tracing activ
38 vaccination activities, including preventive mass vaccination campaigns (PMVCs).
39                                           As mass vaccination campaigns against coronavirus disease 2
40            We also explain recent changes in mass vaccination campaigns against HPV and the potential
41 ic of H1N1 influenza virus in China and with mass vaccination campaigns against influenza during the
42                     In high-burden settings, mass vaccination campaigns are conducted to increase acc
43          Our findings support the use of TCV mass vaccination campaigns as effective population-based
44                                              Mass vaccination campaigns can be successful in vaccinat
45     For example, in Arequipa, Peru, sweeping mass vaccination campaigns conducted yearly over a singl
46 e modeled vaccination strategy is to conduct mass vaccination campaigns every 5 years for children 1-
47                                    Follow-up mass vaccination campaigns for children younger than 5 y
48 , the usefulness of opinion polls to prepare mass vaccination campaigns for specific new vaccines and
49 , where the vast majority of dogs are owned, mass vaccination campaigns have typically depended on a
50 ial need to treat parasitic infection before mass vaccination campaigns in helminth-endemic areas.
51 easured in 254 children before and after two mass vaccination campaigns in Jordan.
52                             But implementing mass vaccination campaigns in large populations within a
53                                      Despite mass vaccination campaigns in many parts of the world, c
54                                      Current mass vaccination campaigns in measles outbreak response
55                                    Following mass vaccination campaigns in the African meningitis bel
56 een substantial funding for large preventive mass vaccination campaigns in the most affected countrie
57 the efficacy of meningococcal vaccine during mass vaccination campaigns in US civilian populations ha
58 s (NmA), MenAfriVac, was first introduced in mass vaccination campaigns of 1-29-year-olds in Burkina
59                                              Mass vaccination campaigns of the population aged 1-29 y
60  to define priority geographical areas where mass vaccination campaigns should be conducted.
61                For WS and ER networks, rapid mass vaccination campaigns significantly reduced infecti
62                        The implementation of mass vaccination campaigns targeting women of childbeari
63 19 variants of concern and in the absence of mass vaccination campaigns targeting young children.
64                                              Mass vaccination campaigns to prevent coronavirus diseas
65          Supplementing these activities with mass vaccination campaigns triggered when low levels of
66                     The impact of the recent mass vaccination campaigns was assessed by evaluating th
67 r of people who received the vaccine through mass vaccination campaigns was several hundredfold highe
68                                              Mass vaccination campaigns with parenteral vaccines, and
69                                              Mass vaccination campaigns with the oral poliovirus vacc
70 ill require new delivery strategies, such as mass vaccination campaigns, and new products targeted at
71 an would support evidence-based planning for mass vaccination campaigns.
72 of a continued focus on testing, even amidst mass vaccination campaigns.
73 al care, obstetrics/gynecology, and targeted mass vaccination campaigns.
74 erages and evaluating one-time, age-specific mass vaccination campaigns.
75 al tool for facilitating inexpensive IPV for mass vaccination campaigns.
76 ed products by non-specialist users, e.g. in mass vaccination campaigns.
77 data are commonly used to assess coverage of mass vaccination campaigns.
78 cts given that many vaccination programs and mass-vaccination campaigns define eligibility in this wa
79                   Moreover, in certain cases mass vaccination can have the counterproductive effect o
80                                      A short mass vaccination catch-up campaign, not yet in the portf
81 inistration [GP practice, local pharmacy, or mass vaccination centre]).
82 e-hundred and eighty-four adults attending a mass-vaccination centre in the UK received a two-dose BN
83    For a mass vaccination campaign involving mass vaccination centres and communication of herd immun
84              The university hosted an onsite mass vaccination clinic using the 2-dose Pfizer-BioNTech
85 n, via continued preventive measures, prompt mass-vaccination, continued vaccine efficacy monitoring,
86 es, and reaffirm the urgent need to continue mass vaccination efforts globally.
87  findings could guide the ongoing and future mass vaccination efforts in sub-Saharan Africa by emphas
88  China-the world's largest population-in the mass vaccination era remains poorly understood.
89 following an accidental point importation or mass vaccination event.
90                     Comparing the results to mass vaccination from the moment an attack is recognized
91 nough rate to justify the discontinuation of mass vaccination from this perspective.
92                                  However, as mass vaccination has progressed, rare but catastrophic c
93  human influenza, such potential benefits of mass vaccination have so far proved elusive.
94 ial of live att avian influenza vaccines for mass vaccination in poultry.
95  it is optimal to target children for dengue mass vaccination in Thailand, whereas young adults shoul
96 RMHC is up to 84% more effective than random mass vaccination in the mid range of vaccine availabilit
97 lion population), whereas in regions without mass vaccination, incidence was 43.8 per 100,000 (3809 c
98 he effectiveness of postrelease targeted and mass vaccinations increased if we assumed that there was
99 valent vaccination programme was the largest mass vaccination initiative in recent US history.
100               Herd immunity achieved through mass vaccination is an effective approach to prevent con
101               Our results suggest that rapid mass vaccination is an effective tool to curb the spread
102                                              Mass vaccination is the primary element of the public he
103  contagion transmission through simultaneous mass vaccination is ubiquitous and often perceived as th
104                                      Despite mass vaccination, it remains a leading cause of death in
105 ccines target adults, although high-coverage mass vaccinations may be logistically more challenging a
106             These data were collected before mass vaccination occurred in the population.
107 employed and trained in order to achieve the mass vaccination of 20 000 children aged 9 months to <=1
108 ed with early detection without resorting to mass vaccination of a population.
109 interruption of rubella transmission through mass vaccination of adolescents and adults, and strength
110                                     Biannual mass vaccination of cattle leaves significant immunity g
111                                Consequently, mass vaccination of cattle with v2RVFH could eradicate r
112 (FMD) in Turkey is controlled using biannual mass vaccination of cattle.
113 ealth approach to rabies control through the mass vaccination of dogs and control of canine populatio
114 atches may provide an innovative approach to mass vaccination of dogs.
115                                   Widespread mass vaccination of domestic dogs reduced the probabilit
116 ding ring-vaccination, spatial-targeting and mass vaccination of high-risk groups.
117 , Soberana may have utility as an option for mass vaccination of the population, especially in resour
118 ing implementation of the current policy for mass vaccination of women of childbearing age an urgent
119 ing HA protein might be a better vaccine for mass-vaccination of commercial chickens in field conditi
120 ing with traced vaccination and switching to mass vaccination only if required.
121 d provide a better response to bioterrorism, mass vaccination, or vaccination of social contacts, so-
122 opulation from 3 weeks up to 13 months after mass vaccination (P = .003).
123 r combination mass drug administration and a mass vaccination program approach to eliminate malaria f
124 ntial to minimize program costs and increase mass vaccination program feasibility.
125 fluenza pandemic, and the start of a measles mass vaccination program.
126     Their concomitant critical importance in mass vaccination programmes may have prompted recent int
127       Governments worldwide are implementing mass vaccination programs in an effort to end the novel
128  the HIV-infection status of participants in mass vaccination programs may be unknown.METHODSThis ran
129 ing potential, supports its potential use in mass vaccination programs.
130                    This has implications for mass vaccination programs.FUNDINGNIH.
131 aggered temporally over 6 months, continuous mass vaccination reaching recommended vaccination covera
132                                      Despite mass vaccination, reported pertussis cases have increase
133 moment an attack is recognized, we find that mass vaccination results in both far fewer deaths and mu
134 e 2019 (COVID-19) vaccines is crucial during mass vaccination rollout to inform the choice of vaccine
135 n which hepatitis A is endemic, and/or under mass-vaccination scenarios.
136                   This study in a nationwide mass vaccination setting suggests that the BNT162b2 mRNA
137                In this study in a nationwide mass vaccination setting, the BNT162b2 vaccine was not a
138 cluding those believed most likely, and that mass vaccination similarly outperforms the existing poli
139 macies rather than larger health systems and mass vaccination sites.
140 ve profound implications for a transition to mass vaccination strategies against human influenza, and
141 ting the country-specific impact of one-time mass vaccination strategies is necessary for ongoing out
142 od would be a value as a potential universal mass vaccination strategy.
143                              Three rounds of mass vaccinations targeting those aged 6 weeks to 14 yea
144 e the potential counterproductive effects of mass vaccination, through compensating for losses in nat
145 he best response to the most likely outcome, mass vaccination thus has the advantage of preventing ou
146                                    Universal mass vaccination (UMV) has been shown to prevent the bur
147  communities to compare the effectiveness of mass vaccination versus targeted vaccination of close co
148 ulosis control, but the expected benefits of mass vaccination will be eroded if strain replacement wi
149 , supplementation of preemptive therapy with mass vaccination will become a cost-effective option.
150                                              Mass vaccination will dramatically reduce the effect of
151                            Assuming biannual mass vaccination with a single-dose primary course, vacc
152                                     In 2010, mass vaccination with a then-new meningococcal A polysac
153                     Interventions, including mass vaccination with a Vi-conjugate vaccine coadministe
154 ntries through the introduction of universal mass vaccination with live attenuated RV vaccines, simil
155  A fell from 0.7% to 0.02% in Chad following mass vaccination with MenAfriVac.
156 y combating the COVID-19 pandemic depends on mass vaccination with suitable vaccines to achieve herd
157 yphoid (ie, ciprofloxacin and azithromycin), mass vaccination with Typbar-TCV did not affect the tota
158 these approaches is currently being used for mass vaccination (with the exception or vaccinia-rabies
159 there is also a substantial probability that mass vaccination would save 200,000 or more lives than t
160 le scenario, the most likely outcome is that mass vaccination would save approximately 100,000 more l

 
Page Top